Furthermore, PHLPP is downregulated in many tumors, and correlates with the growth, tumorigenesis, and metastasis potential of cancer [36, 37], which suggests that PHLPP plays an important role as a negative regulator of the PI3K/AKT pathway in cancer. This evidence concerns the gene AKT1 and cancer.